Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Adult Stem Cells01:33

Adult Stem Cells

33.8K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

5.0K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Lumber Defects01:23

Lumber Defects

516
Lumber defects, which can affect both the appearance and structural integrity of wood, include a variety of growth and manufacturing flaws. Growth defects such as knots and knotholes occur where branches were once attached to the tree trunk, with knotholes forming when these knots fall out. Other natural defects include decay and insect damage, which compromise the wood's strength and durability.
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of a 5-Year-Old Boy with a Blauth Type IIIB Hypoplastic Thumb Reconstructed with a Nonvascularized, Hemilongitudinal Metatarsal Transfer.

Case reports in orthopedics·2019
Same author

Therapeutic Targets for Bone and Soft-Tissue Sarcomas.

International journal of molecular sciences·2019
Same author

Risk factors for surgical site infection after malignant bone tumor resection and reconstruction.

BMC cancer·2019
Same author

The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2019
Same author

[Development of Novel Osteoporosis Screening Methods Using FRAX].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·2019
Same author

Frequent mutations of genes encoding vacuolar H<sup>+</sup> -ATPase components in granular cell tumors.

Genes, chromosomes & cancer·2019

Related Experiment Video

Updated: Jan 31, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

18.0K

A Scaffold-Free Allogeneic Construct From Adipose-Derived Stem Cells Regenerates an Osteochondral Defect in a Rabbit

Takeshi Oshima1, Junsuke Nakase1, Tatsuhiro Toratani1

  • 1Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association
|January 8, 2019
PubMed
Summary

Allogeneic adipose-derived stem cells (ADSCs) promote histological healing of osteochondral defects in rabbits. This study shows ADSC implantation enhances cartilage repair and type II collagen production, suggesting a potential role in regenerative medicine.

More Related Videos

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

16.4K
Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model
09:07

Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model

Published on: February 24, 2017

7.2K

Related Experiment Videos

Last Updated: Jan 31, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

18.0K
Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate
11:31

Repair of a Critical-sized Calvarial Defect Model Using Adipose-derived Stromal Cells Harvested from Lipoaspirate

Published on: October 31, 2012

16.4K
Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model
09:07

Rapid Isolation of BMPR-IB+ Adipose-Derived Stromal Cells for Use in a Calvarial Defect Healing Model

Published on: February 24, 2017

7.2K

Area of Science:

  • Regenerative Medicine
  • Orthopedic Surgery
  • Stem Cell Therapy

Background:

  • Osteochondral defects present a significant clinical challenge due to the limited self-healing capacity of cartilage.
  • Adipose-derived stem cells (ADSCs) are a promising cell source for tissue regeneration owing to their multipotent differentiation potential.

Purpose of the Study:

  • To evaluate the histological healing of osteochondral defects using 3-dimensionally formed, allogeneic ADSCs in a rabbit model.
  • To assess the survival, integration, and chondrogenic potential of implanted ADSCs.

Main Methods:

  • Osteochondral defects were created in the knee trochlear groove of 30 rabbits.
  • Defects were either left empty (control) or filled with allogeneic ADSCs.
  • Macroscopic, histological (Safranin O, modified ICRS score), and immunohistochemical (type II collagen) evaluations were performed at 4, 8, and 12 weeks post-implantation.

Main Results:

  • Significantly improved macroscopic healing scores were observed in the ADSC group at 12 weeks.
  • Histological analysis revealed progressive Safranin O staining and significantly higher modified ICRS scores in the ADSC group at 8 and 12 weeks.
  • Implanted ADSCs demonstrated positive staining for type II collagen, indicating chondrogenic differentiation.

Conclusions:

  • Scaffold-free, allogeneic ADSCs survived, adhered to the defect site, and promoted histological healing in an osteochondral defect rabbit model.
  • ADSC implantation led to increased type II collagen expression over time, supporting cartilage matrix formation.
  • These findings suggest that ADSC implantation is a viable strategy for promoting osteochondral defect repair.